Inflammation & Allergy - Drug Targets (Discontinued)
Title: Editorial from Guest Editor [Hot Topic:Animal Venoms: From Deadly Arsenals (Toxins) to Therapeutic Drug Candidates (Guest Editor: Jean-Marc Sabatier)]
Volume: 10 Issue: 5
Author(s): Jean-Marc Sabatier
Affiliation:
Export Options
About this article
Cite this article as:
Sabatier Jean-Marc, Editorial from Guest Editor [Hot Topic:Animal Venoms: From Deadly Arsenals (Toxins) to Therapeutic Drug Candidates (Guest Editor: Jean-Marc Sabatier)], Inflammation & Allergy - Drug Targets (Discontinued) 2011; 10 (5) . https://dx.doi.org/10.2174/187152811797200632
DOI https://dx.doi.org/10.2174/187152811797200632 |
Print ISSN 1871-5281 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4055 |
Related Articles
-
The Gene Expression Profiles of Medulloblastoma Cell Lines Resistant to Preactivated Cyclophosphamide
Current Cancer Drug Targets Tumor Initiating Cells
Current Pharmaceutical Biotechnology Hypericin Lights Up the Way for the Potential Treatment of Nasopharyngeal Cancer by Photodynamic Therapy
Current Clinical Pharmacology Editorial [Hot Topic: Recent Advances in Antiviral Agents (Executive Editor: Shin-Ru Shih)]
Current Pharmaceutical Design Inhibition of Bacterial Carbonic Anhydrases as a Novel Approach to Escape Drug Resistance
Current Topics in Medicinal Chemistry Targeting IAPs as An Approach to Anti-Cancer Therapy
Current Topics in Medicinal Chemistry Chikungunya Infection and Immunity: An Overview
Current Immunology Reviews (Discontinued) Targeted Cancer Therapy: The Next Generation of Cancer Treatment
Current Drug Discovery Technologies Vitamin D and Metabolic Syndrome: Is There a Link?
Current Pharmaceutical Design Editorial (Hot Topic: Emerging Therapeutic Targets in Inflammation and Allergy Drug Discovery from Patent Perspective)
Recent Patents on Inflammation & Allergy Drug Discovery The Association of Palmitoylethanolamide with Luteolin Decreases Neuroinflammation and Stimulates Autophagy in Parkinson's Disease Model
CNS & Neurological Disorders - Drug Targets ABC Transporters in Neurological Disorders: An Important Gateway for Botanical Compounds Mediated Neuro-Therapeutics
Current Topics in Medicinal Chemistry Evaluation of Clinical Efficacy of Fasudil for the Treatment of Pulmonary Arterial Hypertension
Recent Patents on Cardiovascular Drug Discovery Patent Selections
Recent Patents on Biotechnology Development of Folate-Conjugated PEGylated Poly (d,l-lactide-co-glycolide) Nanoparticulate Carrier for Docetaxel
Current Nanoscience Analysis of Nickel-Binding Peptides in a Human Hepidermoid Cancer Cell Line by Ni-NTA Affinity Chromatography and Mass Spectrometry
Protein & Peptide Letters Foreign Compounds and Intermediary Metabolism: Sulfoxidation Bridges the Divide
Current Drug Metabolism Alterations in Glucose Metabolism on Cognition: A Possible Link Between Diabetes and Dementia
Current Pharmaceutical Design Pannexin Channels: The Emerging Therapeutic Targets
Current Drug Targets Editorial (Thematic Issue: NADPH Oxidase-Derived ROS Signaling and Therapeutic Opportunities)
Current Pharmaceutical Design